Blair William & CO Puma Biotechnology, Inc. Transaction History

Blair William & CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$8.75 - $12.85 $30,100 - $44,204	-3,440 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$20.77 - $42.37 $9,138 - $18,642	440 Added 14.67%	3,440 $251,000
Q4 2018 Feb 14, 2019	BUY	$20.07 - $46.7 $60,210 - $140,100	3,000 New	3,000 $219,000
Q2 2018 Aug 13, 2018	SELL	$48.3 - $68.25 $144,900 - $204,750	-3,000 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$72.0 - $119.75 $216,000 - $359,250	3,000	3,000 $359,000

101

29M

50.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $143M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

Stay updated on Blair William & CO with notifications on news.